The hypomethylating agent Decitabine causes a paradoxical increase in 5-hydroxymethylcytosine in human leukemia cells

The USFDA approved “epigenetic drug”, Decitabine, exerts its effect by hypomethylating DNA, demonstrating the pivotal role aberrant genome-wide DNA methylation patterns play in cancer ontology. Using sensitive technologies in a cellular model of Acute Myeloid Leukemia, we demonstrate that while Deci...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Basudev, McGovern, Andrew, Cui, Yi, Choudhury, Samrat Roy, Cho, Il-Hoon, Cooper, Bruce, Chevassut, Timothy, Lossie, Amy C., Irudayaraj, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894448/
https://www.ncbi.nlm.nih.gov/pubmed/25901663
http://dx.doi.org/10.1038/srep09281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894448/
https://www.ncbi.nlm.nih.gov/pubmed/25901663
http://dx.doi.org/10.1038/srep09281

Ejemplares similares